Mary Polan
Director/Board Member chez QUIDELORTHO CORPORATION
Fortune : 994 180 $ au 31/03/2024
Profil
Mary Lake Polan is currently a Non-Executive Director at Motif BioSciences, Inc., a Director at Chembio Diagnostic Systems, Inc., a Director at NovaTract Surgical, Inc., a Director at NX Prenatal, Inc., a Director at Or-Genix Therapeutics, Inc., an Independent Director at QuidelOrtho Corp., a Member of the National Academy of Medicine (United States), and a Professor at Yale School of Medicine.
Previously, she served as a Director at Wyeth LLC, an Independent Director at Quidel Corp., an Independent Director at Chembio Diagnostics, Inc., a Director at Wyeth Pharmaceuticals LLC, a Director at EpiEP, Inc., a Director at MiraDx, Inc., an Independent Non-Executive Director at Motif Bio Plc, and a Managing Director at Golden Seeds, Inc. She was also a Professor at Stanford University School of Medicine and a Clinical Professor at Columbia University Vagelos College of Physicians & Surgeons.
Dr. Polan received her undergraduate degree from Connecticut College, her graduate degree from the University of California, Berkeley, and her doctorate from Yale School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
QUIDELORTHO CORPORATION
0,03% | 18/03/2024 | 20 738 ( 0,03% ) | 994 180 $ | 31/03/2024 |
Postes actifs de Mary Polan
| Sociétés | Poste | Début |
|---|---|---|
| QUIDELORTHO CORPORATION | Director/Board Member | 01/01/1993 |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Corporate Officer/Principal | - |
Chembio Diagnostic Systems, Inc.
 Chembio Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY. | Director/Board Member | 01/08/2018 |
Or-Genix Therapeutics, Inc.
 Or-Genix Therapeutics, Inc. Household/Personal CareConsumer Non-Durables Or-Genix Therapeutics, Inc. engages in a medical industry. It develops pioneering products to treat skin, hair, and mucous membrane disorders. The company was founded by Yael Schwartz and Craig Abolin and is headquartered in Worcester, MA. | Director/Board Member | - |
NX Prenatal, Inc.
 NX Prenatal, Inc. Medical SpecialtiesHealth Technology NX Prenatal, Inc. is amolecular diagnostics company, which engages in the development of diagnostic assays for adverse pregnancy conditions such as preterm birth. The company was founded by Gail S. Page and Brian D. Brohman and is headquartered in Louisville, KY. | Director/Board Member | - |
| Yale School of Medicine | Corporate Officer/Principal | 01/01/2014 |
NovaTract Surgical, Inc.
 NovaTract Surgical, Inc. Medical SpecialtiesHealth Technology NovaTract Surgical, Inc. manufactures and develops laparoscopic medical devices. It offers NovaTract, a laparoscopic retractor that addresses the need to increase visibility (by using fewer instruments), improves tissue manipulations, provides angle of retraction modifications and reduces the number of ports and incisions. The firm also offers its intra-abdominal retraction system for use in general, colorectal, gynecology, urology, urogynecology, bariatric, and robotic-assisted minimally invasive surgery applications. The company was founded by Eleanor L. Tandler in April 2010 and is headquartered in Agoura Hills, CA. | Director/Board Member | - |
Motif BioSciences, Inc.
 Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Director/Board Member | 01/01/1993 |
Anciens postes connus de Mary Polan
| Sociétés | Poste | Fin |
|---|---|---|
| CHEMBIO DIAGNOSTICS, INC. | Director/Board Member | 25/06/2021 |
| ░░░░░ ░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Mary Polan
| Connecticut College | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
| Yale School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUIDELORTHO CORPORATION | Health Technology |
| Entreprise privées | 14 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Chembio Diagnostics, Inc.
 Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
EpiEP, Inc.
 EpiEP, Inc. Medical SpecialtiesHealth Technology EpiEP, Inc. develops heart-related medical devices. It has developed epicardial access system, EpiAccess, which engages a patent protected pressure-guided needle that is designed to alert physicians of needle tip location during epicardial access procedures. The firm specializes on instruments that facilitates an epicardial approach for patients who benefit from minimally invasive procedures on the surface of the heart. The company was founded by Pamela M. Bunes, Jason Tucker-Schwartz, Srijoy Mahapatra and George T. Gillies in December 2008 and is headquartered in New Haven, CT. | Health Technology |
Chembio Diagnostic Systems, Inc.
Chembio Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Commercial Services |
MiraDx, Inc.
 MiraDx, Inc. Medical/Nursing ServicesHealth Services MiraDx, Inc. provides research and testing for cancer treatments. It offers radiogenomics and cancer chemotherapy. The company was founded by Joanne B. Weidhaas and Frank Slack in February 2008 and is headquartered in Los Angeles, CA. | Health Services |
NovaTract Surgical, Inc.
NovaTract Surgical, Inc. Medical SpecialtiesHealth Technology NovaTract Surgical, Inc. manufactures and develops laparoscopic medical devices. It offers NovaTract, a laparoscopic retractor that addresses the need to increase visibility (by using fewer instruments), improves tissue manipulations, provides angle of retraction modifications and reduces the number of ports and incisions. The firm also offers its intra-abdominal retraction system for use in general, colorectal, gynecology, urology, urogynecology, bariatric, and robotic-assisted minimally invasive surgery applications. The company was founded by Eleanor L. Tandler in April 2010 and is headquartered in Agoura Hills, CA. | Health Technology |
NX Prenatal, Inc.
NX Prenatal, Inc. Medical SpecialtiesHealth Technology NX Prenatal, Inc. is amolecular diagnostics company, which engages in the development of diagnostic assays for adverse pregnancy conditions such as preterm birth. The company was founded by Gail S. Page and Brian D. Brohman and is headquartered in Louisville, KY. | Health Technology |
Golden Seeds, Inc.
 Golden Seeds, Inc. Financial ConglomeratesFinance Golden Seeds, Inc. operates as an investment firm. The private company is based in Las Vegas, NV. The CEO of the company is Anne M. Busquet. | Finance |
Or-Genix Therapeutics, Inc.
Or-Genix Therapeutics, Inc. Household/Personal CareConsumer Non-Durables Or-Genix Therapeutics, Inc. engages in a medical industry. It develops pioneering products to treat skin, hair, and mucous membrane disorders. The company was founded by Yael Schwartz and Craig Abolin and is headquartered in Worcester, MA. | Consumer Non-Durables |
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
